West Pharmaceutical Services (NYSE:WST – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Friday. WST has been the subject of several other reports. Stephens lowered their target price on West Pharmaceutical Services from $420.00 to $390.00 and set an […]
West Pharmaceutical Services (NYSE:WST – Free Report) had its price target boosted by KeyCorp from $440.00 to $470.00 in a research report released on Tuesday morning, Benzinga reports. KeyCorp currently has an overweight rating on the medical instruments supplier’s stock. Several other analysts have also recently weighed in on the company. Jefferies Financial Group raised […]
West Pharmaceutical Services, Inc. (NYSE:WST – Get Free Report) gapped down prior to trading on Thursday . The stock had previously closed at $408.19, but opened at $338.06. West Pharmaceutical Services shares last traded at $327.75, with a volume of 491,081 shares changing hands. Analyst Upgrades and Downgrades Several research firms recently commented on WST. […]